Core Viewpoint - The financial performance of Maide Medical (688310) shows a modest increase in revenue and significant growth in net profit for the third quarter of 2025, indicating potential investment opportunities in the medical equipment sector [2]. Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31% [2]. - The net profit attributable to shareholders reached 8.84 million yuan, reflecting a year-on-year increase of 15.82% [2]. - The third quarter of 2025 saw a single-quarter main revenue of 83.64 million yuan, a substantial year-on-year increase of 54.38% [2]. - The single-quarter net profit attributable to shareholders was 2.79 million yuan, marking a significant year-on-year increase of 224.07% [2]. - The company reported a gross margin of 40.19% and a debt ratio of 29.86% [2]. Business Overview - Maide Medical specializes in the research, development, production, sales, and service of medical consumables and intelligent equipment, integrating technology in medical device processes, automation, and software to create unique product and service advantages [2].
股票行情快报:迈得医疗(688310)2月9日主力资金净卖出685.71万元